Our gastroenterology product portfolio is not only dedicated to the advanced diagnosis of gut-related diseases such as inflammatory bowel disease or pancreatic insufficiency but also perfectly suited for the prevention of gut-related diseases such as colon cancer.
The ELISA tests are suited for single plate or medium-high-throughput analysis on automated readers. Below, you can find the markers and their diagnostic relevance at a glance.
Biomarkers for clinical diagnostics
Biological markers (biomarkers) are measurable indicators for specific conditions. The following biomarkers are relevant in gastroenterology:
- Calprotectin is a highly specific indicator of gastrointestinal inflammation which is used for differentiation of IBD and IBS and for treatment monitoring.
- Haemoglobin is a very efficient marker for colon cancer screening. The antibody-based tests RIDASCREEN® Haemoglobin and RIDASCREEN® Haemo-/Haptoglobin Complex are more specific than Guaiac-based tests. A combined testing of both parameters increases the probability to detect ademonas.
- α1-antitrypsin and sIgA indicate the integrity of the gut wall. This is relevant for monitoring and diagnosing the leaky gut syndrome.
- Pancreatic elastase is used for the detection of pancreatic insufficiency and pancreatitis.
Recent gastroenterology news
You might also be interested in
Questions? Tap into our team’s expertise. We’re here to support you and your business throughout the testing process to ensure your success